Global At-Home Testing Kits Market is expected to grow with the CAGR of 5.3% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-at-home-testing-kits-market
Global at-home testing kits market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in global at-home testing kits market are introducing strong range of service portfolio. This helped companies to maximize the sales with enhanced product portfolio.
Abbott is the dominating player in global at-home testing kits market. The other key players existing in the market includes ACON Laboratories, Inc., Ascensia Diabetes Care Holdings AG, Rapikit, BTNX INC., bioLytical Laboratories Inc., OraSure Technologies, Inc., BD, Cardinal Health, B. Braun Melsungen AG, Piramal Enterprises Ltd., PRIMA Lab SA, Siemens Healthcare GmbH, Quidel Corporation, Bionime Corporation, SA Scientific, ARKRAY USA, Inc., Everlywell, Inc., Nova Biomedical, Eurofins Viracor, Inc. , SelfDiagnostics OU, AdvaCare Pharma, AccuBio Tech Co., Ltd, BioSure UK, Atlas Medical UK, TaiDoc Technology Corporation, LifeScan IP Holdings, LLC, Chembio Diagnostics, Inc., Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Biosynex, Sensing Self, PTE. Ltd, Atomo Diagnostics, RUNBIO BIOTECH CO.,LTD, Clearblue (A Subsidiary of Clear Blue Technologies International Inc), Sterilab Services, Mylan N.V. (A Subsidiary of Viatris Inc), MP BIOMEDICALS and VedaLab among others.
Abbott headquartered in Illinois, U.S. which was established in 1900. The company is engaged in manufacturing and providing healthcare products such as medical devices, diagnostic products and nutritional products for consumers. The company offers wide range of product categories such as consumer & healthcare professional among which consumer are focused category. The company operates their business through established pharmaceutical products, diagnostic products, nutritional products and medical devices while diagnostic products is focused category.
The company has wide global presence across the globe such as North America, South America, Europe, Middle East and Africa, Asia-Pacific. In addition to it, the company also generates its revenue from the various subsidiary companies such as Abbott Administration Inc. (U.S.), Abbott Diabetes Care Inc. (U.S.), Abbott Laboratories Argentina S.A. (Argentina), Abbott Australasia Pty Ltd (Australia) and others.
Ascensia Diabetes Care Holdings AG
Ascensia Diabetes Care Holdings AG headquartered in Basel, Switzerland was founded in year 2016. The company offers wide range of products and solutions related to diabetes and serve the needs of their patients through innovations and expertise. The company offers wide range of product categories contour next blood glucose monitoring systems, contour plus blood glucose monitoring systems and diabetes management solutions among which contour next blood glucose monitoring systems and contour plus blood glucose monitoring systems is market focused category.
The company has presence in Americas, Asia-Pacific, Europe, Middle East and Africa.
BD is headquartered in New Jersey, U.S. which was founded in 1906. The company is engaged in providing innovative solutions related to medical research, diagnosis of infectious disease and cancer, infection prevention, surgical equipment. The company has product categories which are anesthia delivery, biopsy, biosceicne, bio surgery, cervical cancer screening, diabetes, drainage, hazardous drug safety, home care, infection prevention, infusion therapy, interventional specialities, lab automation, medication and supply management, microbiology solutions, molecular diagnostics, patient monitoring and temperature management, prostate health, sharps disposal solutions, software solutions, surgical instruments, syringes and needles, urology and kidney health, vascular access, wound care in which microbiology solutions is market focused category. The company has various business segments medical, life sciences and interventional among which market focused segment is medical.
The company has global presence in Americas, Europe, Middle East and Africa, Asia-Pacific. In addition, company also generates revenue through the subsidiary such as Atto BioScience, Inc. (U.S.), BD Holding S. de R.L. de C.V. (Mexico), BD Norge AS (Norway), Becton Dickinson Argentina S.R.L. (Aregntina), Becton Dickinson Asia Limited (Hong Kong) among others.
Global At-Home Testing Kits Market – Industry Trends and Forecast to 2028
Europe At-Home Testing Kits Market – Industry Trends and Forecast to 2028
Asia-Pacific At-Home Testing Kits Market – Industry Trends and Forecast to 2028
Middle East and Africa At-Home Testing Kits Market – Industry Trends and Forecast to 2028
North America At-Home Testing Kits Market – Industry Trends and Forecast to 2028